Fitch Revises Novartis' Outlook to Negative; 'AA' Affirmed - Fitch Research

Fitch Revises Novartis' Outlook to Negative; 'AA' Affirmed

Fitch Revises Novartis' Outlook to Negative; 'AA' Affirmed - Fitch Research
Fitch Revises Novartis' Outlook to Negative; 'AA' Affirmed
Published Sep 18, 2017
2780 words — Published Sep 18, 2017
Price US$ 149.00  |  Buy this Report Now

About This Report

  
Brief Excerpt:

Fitch Revises Novartis' Outlook to Negative; 'AA' Affirmed 18 Sep 2017 1:08 PM (EDT) Fitch Ratings-London-18 September 2017: Fitch Ratings has revised Switzerland-based pharmaceutical company Novartis AG's Outlook to Negative from Stable....

  
Report Type:

Press Release

Company(ies)
Novartis AG , Novartis Finance S.A. , Novartis Securities Investment Limited , Novartis Capital Corporation
Ticker(s)
NOT
Format:
HTML HTML
Buy Now

Fitch Research—Fitch Ratings is a leading global rating agency committed to providing the world's credit markets with independent, timely and prospective credit opinions. Built on a foundation of organic growth and strategic acquisitions, Fitch Ratings has grown rapidly during the past decade gaining market presence throughout the world and across all fixed income markets.

About the Author


Cite this Report

  
MLA:
Fitch Research. "Fitch Revises Novartis' Outlook to Negative; 'AA' Affirmed" Sep 18, 2017. Alacra Store. May 13, 2025. <http://www.alacrastore.com/fitch-credit-research/Fitch-Revises-Novartis-Outlook-to-Negative-AA-Affirmed-1029328_pr_frame>
  
APA:
Fitch Research. (). Fitch Revises Novartis' Outlook to Negative; 'AA' Affirmed Sep 18, 2017. New York, NY: Alacra Store. Retrieved May 13, 2025 from <http://www.alacrastore.com/fitch-credit-research/Fitch-Revises-Novartis-Outlook-to-Negative-AA-Affirmed-1029328_pr_frame>
  
US$ 149.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.